Skip to main content

IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.

Publication ,  Journal Article
Maier, LM; Lowe, CE; Cooper, J; Downes, K; Anderson, DE; Severson, C; Clark, PM; Healy, B; Walker, N; Aubin, C; Oksenberg, JR; Hauser, SL ...
Published in: PLoS Genet
January 2009

Multiple sclerosis (MS) and type 1 diabetes (T1D) are organ-specific autoimmune disorders with significant heritability, part of which is conferred by shared alleles. For decades, the Human Leukocyte Antigen (HLA) complex was the only known susceptibility locus for both T1D and MS, but loci outside the HLA complex harboring risk alleles have been discovered and fully replicated. A genome-wide association scan for MS risk genes and candidate gene association studies have previously described the IL2RA gene region as a shared autoimmune locus. In order to investigate whether autoimmunity risk at IL2RA was due to distinct or shared alleles, we performed a genetic association study of three IL2RA variants in a DNA collection of up to 9,407 healthy controls, 2,420 MS, and 6,425 T1D subjects as well as 1,303 MS parent/child trios. Here, we report "allelic heterogeneity" at the IL2RA region between MS and T1D. We observe an allele associated with susceptibility to one disease and risk to the other, an allele that confers susceptibility to both diseases, and an allele that may only confer susceptibility to T1D. In addition, we tested the levels of soluble interleukin-2 receptor (sIL-2RA) in the serum from up to 69 healthy control subjects, 285 MS, and 1,317 T1D subjects. We demonstrate that multiple variants independently correlate with sIL-2RA levels.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PLoS Genet

DOI

EISSN

1553-7404

Publication Date

January 2009

Volume

5

Issue

1

Start / End Page

e1000322

Location

United States

Related Subject Headings

  • Solubility
  • Multiple Sclerosis
  • Interleukin-2 Receptor alpha Subunit
  • Humans
  • Genotype
  • Genetic Predisposition to Disease
  • Genetic Heterogeneity
  • Disease Susceptibility
  • Diabetes Mellitus, Type 1
  • Developmental Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Maier, L. M., Lowe, C. E., Cooper, J., Downes, K., Anderson, D. E., Severson, C., … Hafler, D. A. (2009). IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet, 5(1), e1000322. https://doi.org/10.1371/journal.pgen.1000322
Maier, Lisa M., Christopher E. Lowe, Jason Cooper, Kate Downes, David E. Anderson, Christopher Severson, Pamela M. Clark, et al. “IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.PLoS Genet 5, no. 1 (January 2009): e1000322. https://doi.org/10.1371/journal.pgen.1000322.
Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet. 2009 Jan;5(1):e1000322.
Maier, Lisa M., et al. “IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.PLoS Genet, vol. 5, no. 1, Jan. 2009, p. e1000322. Pubmed, doi:10.1371/journal.pgen.1000322.
Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, Clark PM, Healy B, Walker N, Aubin C, Oksenberg JR, Hauser SL, Compston A, Sawcer S, International Multiple Sclerosis Genetics Consortium, De Jager PL, Wicker LS, Todd JA, Hafler DA. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet. 2009 Jan;5(1):e1000322.

Published In

PLoS Genet

DOI

EISSN

1553-7404

Publication Date

January 2009

Volume

5

Issue

1

Start / End Page

e1000322

Location

United States

Related Subject Headings

  • Solubility
  • Multiple Sclerosis
  • Interleukin-2 Receptor alpha Subunit
  • Humans
  • Genotype
  • Genetic Predisposition to Disease
  • Genetic Heterogeneity
  • Disease Susceptibility
  • Diabetes Mellitus, Type 1
  • Developmental Biology